Drug Profile
Research programme: antibacterials - Karo Bio
Alternative Names: Antibacterial research programme - Karo BioLatest Information Update: 19 Sep 2006
Price :
$50
*
At a glance
- Originator Karo Bio USA
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 09 Jul 2001 Preclinical development for Bacterial infections in USA (Unknown route)